Green Valley Investors as of Sept. 30, 2015
Portfolio Holdings for Green Valley Investors
Green Valley Investors holds 27 positions in its portfolio as reported in the September 2015 quarterly 13F filing
| Company (Ticker) | Portfolio Weight | Valued At | Change in Shares | Share Count | Share Price |
|---|---|---|---|---|---|
| Express Scripts Holding | 15.7 | $733M | 9.1M | 80.96 | |
| Celgene Corporation | 10.7 | $498M | 4.6M | 108.17 | |
| Johnson & Johnson (JNJ) | 7.3 | $338M | 3.6M | 93.35 | |
| Gilead Sciences (GILD) | 6.3 | $295M | 3.0M | 98.19 | |
| LKQ Corporation (LKQ) | 4.7 | $221M | 7.8M | 28.36 | |
| TJX Companies (TJX) | 4.6 | $214M | 3.0M | 71.42 | |
| Stryker Corporation (SYK) | 4.4 | $207M | 2.2M | 94.10 | |
| Walt Disney Company (DIS) | 4.4 | $204M | 2.0M | 102.20 | |
| Wal-Mart Stores (WMT) | 4.2 | $195M | 3.0M | 64.84 | |
| Marriott International (MAR) | 3.9 | $180M | 2.6M | 68.20 | |
| Twenty-first Century Fox | 3.5 | $162M | 6.0M | 26.98 | |
| Thermo Fisher Scientific (TMO) | 3.1 | $147M | 1.2M | 122.28 | |
| International Flavors & Fragrances (IFF) | 3.1 | $145M | 1.4M | 103.26 | |
| Valeant Pharmaceuticals Int | 3.1 | $143M | 800k | 178.38 | |
| Praxair | 2.6 | $122M | 1.2M | 101.86 | |
| Abbott Laboratories (ABT) | 2.6 | $121M | 3.0M | 40.22 | |
| Allergan | 2.3 | $109M | 400k | 271.81 | |
| Potash Corp. Of Saskatchewan I | 2.3 | $108M | 5.3M | 20.55 | |
| Procter & Gamble Company (PG) | 2.1 | $99M | 1.4M | 71.94 | |
| Henry Schein (HSIC) | 1.7 | $78M | 590k | 132.72 | |
| Air Products & Chemicals (APD) | 1.6 | $77M | 600k | 127.58 | |
| Dow Chemical Company | 1.4 | $68M | 1.6M | 42.40 | |
| Vertex Pharmaceuticals Incorporated (VRTX) | 1.1 | $52M | 500k | 104.14 | |
| Colgate-Palmolive Company (CL) | 0.9 | $44M | 700k | 63.46 | |
| Monsanto Company | 0.9 | $43M | 500k | 85.34 | |
| Medivation | 0.7 | $34M | 800k | 42.50 | |
| SYSCO Corporation (SYY) | 0.6 | $29M | 749k | 38.97 |
